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and it is thought that in excess of 100 million people may be
exposed to it, some of them at chronic levels, making it a
major public health problem. Soil, in mining areas or near
smelters, may be contaminated with high levels of arsenic. The
U.S. Environmental Protection Agency (EPA) has established
the maximum contaminant level of arsenic in public drinkingE-mail address: gulingokcenmd@gmail.com.
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Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://crwater to be set at ten parts per billion. The American Con-
ference of Governmental Industrial Hygienists (ACGIH)
determined the maximum contaminant level for arsenic in the
air to be 10 mg/m3. Natural levels of arsenic in the soil usually
range from 1 to 40 mg/kg, but pesticide application or waste
disposal can produce much higher values. (ATSDR, 2000).
Although extensive research has focused on investigating
arsenic carcinogenicity, there is growing evidence to indicate
that arsenic also has a deleterious effect on the auditory sys-
tem. This paper will briefly describe the general information of
arsenic and extend more detailed description to ototoxic effect
of arsenic.gy Head and Neck Surgery. Production and hosting by Elsevier (Singapore)
eativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
The total arsenic measurement methods used by several authors.
Authors Sample Method Preparation method
Valentine et al., 1979 Blood and hair HGAAS Wet ash with nitric/perchloric acids; reduction with sodium borohydride
Foa et al., 1984 Blood HGAAS Wet ash with nitric/perchloric acids; reduction with sodium borohydride
Curatola et al., 1978 Hair HGAAS Wet ashing with nitric/sulfuric acids and hydrogen peroxide; reduction
to arsine with sodium borohydride
Agahian et al., 1990 Nails HGAAS Wet ashing with nitric/sulfuric acids and hydrogen peroxide; reduction
to arsine with sodium borohydride
Mushak et al., 1977 Soft tissue GFAAS Digestion with nitric/sulfuric acids; complexation with DDDC in
potassium iodide; extraction with chloroform
Pinto et al., 1976 Urine Colorimetric
photometry
Digestion with nitric and perchloric acid; reduction with tin chloride;
generation arsine by addition of zinc; reaction with SDDC
Landsberger and Simsons, 1987 Urine NAA Irradiate epithermally
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Because arsenic has both metallic and nonmetallic prop-
erties, it is chemically classified as a metalloid. Metallic
arsenic is a steel-gray solid material but in nature it is usually
found in combination with other elements. When combined
with oxygen, chlorine, and sulfur it is referred to as inorganic
arsenic, but combined with carbon and hydrogen it is called
organic arsenic. (ATSDR, 2000) Inorganic arsenic is more
harmful than organic arsenic compounds. The main inorganic
arsenic compounds found in water are specifically arsenite
(AsIII) and arsenate (AsV). (Feldmann and Krupp, 2011) The
molecular forms of arsenic compounds present in food are
more variable and also non-toxic arsenic compounds have
been detected in food. These compounds are generally known
as organoarsenicals and are mostly found in marine food
(especially fish) and constitute more than 85% of total arsenic
concentrations. (Feldmann and Krupp, 2011) Another arsenic
compound group is arsenic-containing ribofuranosides, known
as arsenosugars. but there is insufficient information regarding
their toxicity. (Feldmann and Krupp, 2011).
2. Arsenic exposure
Globally, a large number of people are chronically exposed
to arsenic. Although arsenic is found naturally in the soil, air
and water. It can also be detected in heavy metal ores such as
copper and lead. Also coal and waste products often contain
some arsenic. Exposure to arsenic occurs via oral, respiratory
or dermal routes. In some mining areas, smelting sites and
industrial zones, there are high levels of arsenic in the soil.
High levels of arsenic can also be detected in some agricul-
tural areas where pesticides are used and in regions where
there are natural arsenic deposits. (Beamer et al., 2014; Menka
et al., 2014) Furthermore, arsenic is found in water resources,
particularly in groundwater in areas where the soil contains
more arsenic. Most arsenic in food is found in seafood, rice/
rice cereal, mushrooms, and poultry. The arsenic usually found
in fish is less harmful organic forms of arsenic but some
seaweeds may contain more harmful inorganic forms of
arsenic. (ATSDR, 2000).
Another problem associated with arsenic exposure is the
co-exposure of arsenic with other substances, such as lead,cadmium, fluoride, polyaromatic hydrocarbons, and pesti-
cides. (Andrade et al., 2015; Estrada-Capetillo et al., 2014;
Huang et al., 2013) Co-exposures may affect arsenic meta-
bolism and can be synergistic or antagonistic. To understand
the possible effects of co-exposure, randomized controlled
animal studies and human studies analyzing data of groups
such as miners in a multisystem way are required.
3. Metabolism of arsenic
Arsenic metabolism is complex and metabolites depend on
the received arsenic compounds, administration route, and cell
type used for the elimination of arsenic (Stice et al., 2016).
During the metabolism of arsenic, those arsenic compounds
are formed: methylated arsenicals such as DMAV (Dimethy-
larsinic acid), MMAV (Monomethylarsonic acid), DMAIII
(Dimethylarsinous acid), and MMAIII (Monomethylarsonous
acid) and As-glutathione (GSH) and a recently determined
type of arsenicals, thiolated as compounds, including
DMMTAV (Dimethylmonothioarsinic acid), DMDTAV
(Dimethyldithioarsinic acid) and DMMTAV (Dimethylmono-
thioarsinic acid) conjugates. Although it has been established
in which human tissues these metabolites are present, their
role in toxicity has not yet been full clarified (Rehman and
Naranmandura, 2012). However, certain metabolites are
known to be more likely to cause some toxicity. For example,
it is shown that MMA III and DMA III are more genotoxic,
and DEMTAV is more cytotoxic (Mass et al., 2001; Kojima
et al., 2005). Usually trivalent arsenicals are more toxic than
pentavalent arsenicals(Styblo et al., 2000).
Besides their toxicity, some specific arsenic compounds are
used in treatment of certain cancers (Antman, 2001). For
example, arsenic trioxide (As2O3, ATO, Trisenox) has been
used in treatment of acute promyelocytic leukemia (APL) (Liu
et al., 2012).
4. Exposure assessments
As arsenic is found in multiple forms and diverse envi-
ronments, assessing arsenic exposure is complex; there may be
other metals in the same environment as the arsenic, such as
cadmium and fluoride, or microorganisms might affect the
arsenic metabolism. Atomic absorption spectrophotometry
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arsenic in the body and samples can be prepared in different
ways: (Valentine et al., 1979; Foa et al., 1984; Curatola et al.,
1978; Agahian et al., 1990; Mushak et al., 1977) Chroma-
tography technique can be used (Pinto et al., 1976) and
Neutron activation analysis (INAA) can be used to detect
arsenic in liquids and soft tissues (Landsberger and Simsons,
1987). However, there is no standard method. The total
arsenic measurement methods used by several authors are
summarized in the Table 1.
Different biologic measurement methods reflect different
time frames of exposure. For instance, urinary arsenic reflects
acute exposure, and arsenic in the nails reflects exposure over
several months (Marchiset-Ferlay et al., 2012).
5. Arsenic toxicity
Arsenic exposure affects all body systems: cardiovascular,
nervous, hepatobiliary, gastrointestinal, renal, dermatologic
and respiratory systems (Tchounwou et al., 2003). It is known
that arsenic also has carcinogenic effects. In regions with high
levels of arsenic, mortality rates for cancers of bladder, kidney,
skin, and liver are higher (Chappell et al., 1997).5.1. Mechanisms of toxicity and carcinogenicityThe major mechanism of arsenic related toxicity is oxida-
tive stress (Shi et al., 2004). Oxidative stress can cause dete-
rioration of cellular signaling pathways and affect multiple
systems. As a result of the accumulation of free radicals; cell
death, abnormal gene expressions, and degradation of DNA,
lipids, and proteins are seen. The methylated form of arsenic
inhibits DNA repair processes (Mass et al., 2001). Trivalent
arsenicals can inhibit more than 200 enzymes by binding thiol
or sulfhydryl groups to proteins. Pentavalent arsenicals can
interchange with phosphate, which happens on many
pathways (Hughes, 2002). Possible carcinogenic mechanisms
following arsenic exposure are progression of carcinogenesis,
altered DNA repair, p53 suppression, altered DNA methyl-
ation patterns and gene amplifications (Miller et al., 2002).
Also, arsenic induced remission in acute promyelocytic
leukemia because of its apoptosis effect in malignant
cells (Diaz et al., 2005).5.2. Arsenic ototoxicityIn the literature, studies on both humans and animals reveal
the ototoxicity of arsenic.
5.2.1. Effects in animals and in vivo studies
One of the studies on arsenic ototoxicity in animals is that
of Anniko, who investigated the acute effect of atoxyl (organic
arsenical drug) on guinea-pig cochlea. In this study Reissner's
membrane degeneration, mitochondria and cytoplasm injury
in the cells were detected (Anniko, 1976a). In another study by
Anniko, investigating the chronic effects of arsenic, microvilliloss and depressions in epithelial cell of the stria vascularis
were detected (Anniko, 1976b).
Arsenic deposition was detected in the nervous system of
rats (Garcia-Chavez et al., 2006). In neurotoxicity studies,
after rats had been exposed to arsenic, there was decreased
neurofilament light subunit (NF-L) in the sciatic
nerve (Vahidnia et al., 2006). Also it is shown that arsenic
affects one of the major components of neurons, tau protein
(MAP-tau), a member of the microtubule protein family,
which is predominantly associated with phosphorylation of
microtubules of the axons. Giasson et al. demonstrated
hyperphosphorylation of tau-proteins in Chinese hamster
ovary (CHO) cells in vitro following treatment with
arsenite (Giasson et al., 2002). These studies on neurotoxicity
indicate that arsenic may be involved in the cascade leading to
deregulation of tau function associated with neuro-
degeneration. In a study on the effect of arsenic on cultured rat
astroglia, decreased cell viability and increased DNA damage
were detected (Jin et al., 2004).
Arsenic increases the toxic effect of lead and cadmium in
brain cells of the cerebellum and cortex, and has a synergistic
toxic effect on these metals (Gu et al., 2009). In another study on
rats using arsenic, cadmium and lead, the total neurotoxicity
caused by these three heavymetals were found to be higher than
expected or theoretically predicted (Rai et al., 2010).
5.2.2. Observations in human
The ototoxicity of arsenic was also supported with human
studies. Sensorineural hearing loss was reported in individuals
exposed to arsenic. In a study conducted in Inner Mongolia, a
region in China rich in arsenic, there was statistically signifi-
cantly more hearing loss cases in an arsenic affected village,
compared with an unaffected village (Guo et al., 2007). In a
study by Bencko and Symon, in which they confirmed
elevated arsenic levels in blood, urine and hair samples, they
detected hearing loss at 125 Hz, 250 Hz and 8000 Hz in
children aged 10 years old who lived in an area polluted with
arsenic (Bencko et al., 1977). Contrary to expectations, during
an investigation of public schools near a copper smelter, six
children with high urinary arsenic levels had no hearing loss in
a pure tone audiometry test (Milham, 1977). In a national
population-based study on individuals above the age of 50,
urinary concentrations of environmental chemicals were
measured and hearing loss was assessed using
questionnaires (Shiue, 2013). It was found that urinary arsenic
concentrations of acid and 2, 4, 5-trichlorophenol concentra-
tions were significantly associated with hearing disorders. In a
survey of 2535 adolescents in the United States, lead and
mercury levels in the blood, urinary cadmium levels, and
urinary arsenic levels were analysed, and the adjusted odds
ratios were calculated using multivariate logistic regression
analysis for hearing loss. In cases showing high blood levels of
lead, there was an increased odds of high-frequency hearing
loss; and in cases of high blood levels of cadmium, increased
odds of low-frequency hearing loss were detected. However
there was no overall association determined between quartiles
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loss (Shargorodsky et al., 2011).
In one of the studies assessing occupational exposure,
investigating the isolated effect of arsenic on hearing in mine
workers with blood arsenic levels and hearing thresholds of
0.5, 1, 2, 3, 4, and 6 kHz frequencies, hearing thresholds were
increased for each frequency in the group consisting of mine
workers who had been exposed to chronic levels of arsenic and
had high blood levels of arsenic, compared with mine workers
who hadn't been exposed to arsenic (Kesici et al., 2016).
However, in this current study a correlation was not detected
between arsenic levels and hearing thresholds and this result
was attributed to blood arsenic levels reflecting short-term
exposure. In a similar study on gold miners, Saunders et al.
measured fingernail metal levels, Bekesy-type pure-tone
thresholds and distortion product otoacoustic emission
(DPOAE) levels of 59 subjects (Saunders et al., 2013).
Widespread hearing loss was evident, but no relationship be-
tween heavy metal levels and auditory test results could be
identified, although they did find a significant relationship
between arsenic concentrations and DPOAE amplitude at
2 kHz in the low frequency group.
In a study by Chuang et al. on factory workers, blood levels
of selenium, lead, manganese, and arsenic were measured but
arsenic could not be identified as a cause for hearing loss in
multiple linear regressions analysis. In this study it was
identified that selenium has a protective effect on auditory
function and lead causes significant increases in hearing
thresholds (Chuang et al., 2007). In a study on workers
investigating blood levels of manganese, copper, zinc, arsenic,
cadmium and lead, and hearing thresholds, this was the result:
Lead was the only metal found in the blood, which is signif-
icantly correlated with hearing loss, following adjustment for
age and noise level, using the logistic regression model
analysis (Hwang et al., 2009).
In studies on humans, because of co-exposure to other
heavy metals, it is hard to investigate the isolated effect of
arsenic in terms of ototoxicity. Therefore all possible heavy
metals were examined and an adjustment analysis was applied
by using logistic regression model analysis in the studies, and
this situation causes an important limitation in human toxicity
studies. It can be said that arsenic have ototoxic effect but
further studies investigating isolated ototoxic effect of arsenic
are needed. Furthermore, until now, pure tone audiometry was
used in studies on the effect of arsenic on the hearing system.
For a more detailed analysis on the effect of arsenic on the
hearing system and for it to be better understood, the use of
electrophysiologic measurements such as electro-
cochleography, otoacoustic emissions, and evoked response
audiometry is required.References
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